The Relationship Between Interleukin-4 Levels and Cardiovascular Events in Patients with Chronic Kidney Disease

References

• Levin A, Tonelli M, Bonventre J, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017;390:1888–1917. doi:10.1016/S0140-6736(17)30788-228434650
   PubMed Web of Science ®Google Scholar
• Kelsey R. Cardiovascular disease: chronic kidney disease: a risk factor for stroke and bleeding in patients with atrial fibrillation. Nat Rev Nephrol. 2012;8(10):551. doi:10.1038/nrneph.2012.16822945488
   PubMedGoogle Scholar
• Foley RN, Murray AM, Li S. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16(2):489–495. doi:10.1681/ASN.200403020315590763
   PubMed Web of Science ®Google Scholar
• Levin A, Djurdjev O, Barrett B, et al. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. Am J Kidney Dis. 2001;38(6):1398–1407. doi:10.1053/ajkd.2001.2927511728982
   PubMed Web of Science ®Google Scholar
• Ninomiya T, Kiyohara Y, Kubo M, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama study. Kidney Int. 2005;68(1):228–236. doi:10.1111/j.1523-1755.2005.00397.x15954912
   PubMed Web of Science ®Google Scholar
• Cachofeiro V, Goicochea M, de Vinuesa SG, et al. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int. 2008;74(Suppl 111):S4–S9.
   Web of Science ®Google Scholar
• Naito K, Anzai T, Yoshikawa T, et al. Impact of chronic kidney disease on postinfarction inflammation, oxidative stress, and left ventricular remodeling. J Card Fail. 2008;14(10):0–838. doi:10.1016/j.cardfail.2008.07.233
   Web of Science ®Google Scholar
• Gupta J, Mitra N, Kanetsky PA, et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol. 2012;7:1938–1946. doi:10.2215/CJN.0350041223024164
   PubMed Web of Science ®Google Scholar
• Eustace JA, Astor B, Muntner PM, et al. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int. 2004;65:1031–1040. doi:10.1111/j.1523-1755.2004.00481.x14871424
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Wanner C, Metzger T, et al. Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? Kidney Int. 2002;62:1791–1798. doi:10.1046/j.1523-1755.2002.00637.x12371981
   PubMed Web of Science ®Google Scholar
• Carrero JJ, Stenvinkel P. Inflammationin end-stage renal disease–what have welearnedin10 years? Semin Dial. 2010;23:498–509. doi:10.1111/j.1525-139X.2010.00784.x21039875
   PubMed Web of Science ®Google Scholar
• Jankowska M, Cobo G, Lindholm B, et al. Inflammation and protein-energy wasting intheuremicmilieu. Contrib Nephrol. 2017;191:58–71.28910791
   PubMed Web of Science ®Google Scholar
• Sun J, Axelsson J, Machowska A, et al. Biomarkers of cardiovascular disease and mortality risk in patients with advanced CKD. Clin J Am Soc Nephrol. 2016;11:1163–1172. doi:10.2215/CJN.1044101527281698
   PubMed Web of Science ®Google Scholar
• Kooman JP, Kotanko P, Schols AM, et al. Chronic kidney disease and premature ageing. Nat Rev Nephrol. 2014;10:732–742.25287433
   PubMed Web of Science ®Google Scholar
• Amdur RL, Feldman HI, Gupta J, et al. Inflammation and progression of CKD: the CRIC study. Clin J Am Soc Nephrol. 2016;11:1546–1556. doi:10.2215/CJN.1312121527340285
   PubMed Web of Science ®Google Scholar
• Ouyang BS, Che JL, Gao J, et al. [Effects of electroacupuncture and simple acupuncture on changes of IL-1, IL-4, IL-6 and IL-10 in peripheral blood and joint fluid in patients with rheumatoid arthritis]. Zhongguo Zhen Jiu. 2010;30:840–844.Chinese.21058483
   PubMedGoogle Scholar
• Ursaciuc C, Surcel M, Ciotaru D, et al. Regulatory T cells and TH1/TH2 cytokines as immunodiagnosis keys in systemic autoimmune diseases. Roum Arch Microbiol Immunol. 2010;69:79–84.21235134
   PubMedGoogle Scholar
• Andrassy KM. Comments on ‘KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease’. Kidney Int. 2013;84(3):622–623. doi:10.1038/ki.2013.243
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-0000619414839
   PubMed Web of Science ®Google Scholar
• Xiao X, Du C, Yan Z, et al. Inhibition of necroptosis attenuates kidney inflammation and interstitial fibrosis induced by unilateral ureteral obstruction. Am J Nephrol. 2017;46(2):131–138. doi:10.1159/00047874628723681
   PubMed Web of Science ®Google Scholar
• Hanatani S, Izumiya Y, Araki S, et al. Abstract 11021: akt1-mediated skeletal muscle growth attenuates renal interstitial fibrosis and inflammation in obstructive nephropathy. circulation. 2012;A11021.
   Web of Science ®Google Scholar
• Yuhao S, Ying H, Ying J, et al. The association between serum retinol-binding protein 4 levels and cardiovascular events in patients with chronic kidney disease. Lab Med. 2020.
   Web of Science ®Google Scholar
• Nelms K, Keegan AD, Zamorano J, et al. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999;17:701–738. doi:10.1146/annurev.immunol.17.1.70110358772
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145–173. doi:10.1146/annurev.iy.07.040189.0010452523712
   PubMed Web of Science ®Google Scholar
• Guenova E, Hoetzenecker W, Hoerber S, et al. Systemic IL-4 treatment suppresses IL-23 and abrogates inflammatory responses in T cell mediated delayed type hypersensitivity. J Investig Dermatol. 2010.
   Web of Science ®Google Scholar
• Bao L, Shi VY, Chan LS. IL-4 up-regulates epidermal chemotactic, angiogenic, and pro-inflammatory genes and down-regulates antimicrobial genes in vivo and in vitro: relevant in the pathogenesis of atopic dermatitis. Cytokine. 2013;61:419–425. doi:10.1016/j.cyto.2012.10.03123207180
   PubMed Web of Science ®Google Scholar
• Lavoie-Lamoureux A, Moran K, Beauchamp G, et al. IL-4 activates equine neutrophils and induces a mixed inflammatory cytokine expression profile with enhanced neutrophil chemotactic mediator release ex vivo. Am J Physiol Lung Cell Mol Physiol. 2010;299:L472–82. doi:10.1152/ajplung.00135.200920639353
   PubMed Web of Science ®Google Scholar